Cryo-Cell International, Inc.(CCEL)
700 Brooker Creek Blvd.
Oldsmar, FL 34677
Toll Free: 800-786-7235
Cryo-Cell International, Inc. was established in 1989 with a primary focus on the cryopreservation of umbilical cord (U-Cord®) stem cells for family use. Since our inception, we have been committed to the development and adoption of industry best practices and technologies.
Cord blood stem cell transplants have already changed-and saved-thousands of lives around the world. What's more, science is honing in on other miraculous uses for these precious cells, potentially impacting countless numbers of lives in the future.
Ever-committed to the highest quality, we treat every specimen of umbilical cord blood as if it were our own. Every sample we receive, process and preserve represents a potentially life-saving treatment for a child. This concept fuels our resolve to only hire the most talented candidates, develop and implement the most effective training and continuously fine-tune our processes. From the design and specifications of our collection kit, to the choice of each supplier, our dedication to quality remains unwavering.
Cryo-Cell International, Inc. ("the Company" or "Cryo-Cell") operates in one reportable segment and is principally engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord®) blood stem cells for family use. The Company, in combination with its global affiliates currently stores over 200,000 cord blood specimens worldwide for the exclusive benefit of newborn babies and possibly other members of their families. The Company is one of the world's largest and most established private family cord blood stem cell banks in terms of the number of specimens preserved. Its headquarters facility in Oldsmar, Florida handles all aspects of its U.S.-based business operations, including the processing and storage of specimens. The specimens are stored in commercially available cryogenic storage units at the Company's technologically and operationally advanced facility in Oldsmar, Florida.
In recent years, the Company has expanded its research and development ("R&D") activities to develop technologies related to stem cells other than umbilical cord blood stem cells such as fetal and maternal stem cells harvested from the placenta. During 2006, the Company discovered novel technology related to menstrual stem cells. In November 2007, the Company announced the launch of its C'elleSM service related to this patent-pending technology, and the Company continues to focus its current research and development activities principally on the C'elle service and related new menstrual stem cell technologies. The Company is actively marketing the C'elle service which is available both through a bundled offer with the Company's U-Cord service and on a stand-alone basis.
Employees: At November 30, 2009, there are 48 full-time employees and 1 part-time employee on the staff of the Company. Additional employees and staff will be hired on an "as needed" basis. The Company believes its relationship with its employees is good. None of our employees are members of any labor union, and we are not a party to any collective bargaining agreement.
Here's a video which shows the importance of saving cord blood: http://video.foxnews.com/11461523/cord-blood-miracle/?category_id=949437d0db05ed5f5b9954dc049d70b0c12f2749
Cryo-Cell International, Inc. holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron's research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer's disease, stroke, and spinal cord injury.
For more information, visit Saneron's Web site: www.saneron-ccel.com
Cryo-Cell is International
In order to provide the Cryo-Cell U-Cord® Stem Cell Preservation Service abroad, we are establishing affiliates in countries around the world. Currently, we have affiliates in the following areas:
See page 15 of SEC filing for further details: http://www.sec.gov/Archives/edgar/data/862692/000119312511189394/d10q.htm
- Cryo-Cell De Mexico
- Asia Cryo-Cell Private Limited (India, Bangladesh, Nepal, Pakistan and Sri Lanka)
- Cryo-Cell de Venezuela
- China: S-Evans Biosciences, Inc. ("SEB")
- Germany: Innovative Medical Solutions SRL ("IMS")
- Nicaragua: Innovagen, S.A. ("Innovagen")
- Pakistan: Cryo-Cell Pakistan (Pvt.) Limited ("Pakistan")
- Curacao: Link-Cell N.V. ("Curacao"),
- Costa Rica: Stem Cells Costa Rica SA ("Costa Rica")
- LifeCell International Privat Limited offers services in India. LifeCell was the first private cord blood bank in India, which has a birth rate of 25 million per year, and the first to be accredited by AABB.
C'elle distributor opportunity for doctors that specialize in female issues. See video:
Cord Blood Bank Comparison Criteria
All family cord blood banks are not created equal. There are many cord blood banks, all offering similar services. So how do you choose? Consider the following criteria as helpful guidelines in making the decision that is best for your family.
A good indication of whether a company will be around in the future is sometimes how long they've been in business in the past. So look for a cord blood bank that possesses a strong track record. Founded in 1989, Cryo-Cell is one of the largest and most established family cord blood banks.
As with any business, the cord blood bank you choose should be profitable-after all, it's the only way to stay in business. As a publicly traded company, Cryo-Cell Cord Blood Bank is governed by the SEC (Securities and Exchange Commission), which means our financial information is audited by an independent firm, and is available to the public. Unless a company is publicly traded, it is difficult to determine their financial status.
In May 2005, the U.S. Food and Drug Administration (FDA) began regulating family cord blood banks through promulgation of 21 CFR 1271, current Good Tissue Practices. Beyond the federal government, several states (New York, New Jersey and Maryland) have applicable regulations. In addition, several organizations offer accreditation to their standards-AABB is one.
Cryo-Cell is FDA registered, cGMP-/cGTP-compliant and is licensed in all three states requiring licenses. In addition to being AABB accredited, we are ISO 9001:2008 certified by BSI, an internationally recognized, quality assessment organization. Our list of licenses and accreditations make Cryo-Cell the recognized quality leader.
Control of Processing and Storage
Make sure the cord blood bank you choose is not simply a marketing outlet. Some companies do not perform their own processing or storage. Cryo-Cell, however, operates its own state-of-the-art processing, testing and cryopreservation operation. We are in complete control of every step, ensuring the highest quality available today.
Certainly one measure to validate a company's laboratory operation is whether or not the cells are useful in transplant upon thawing. Every sample Cryo-Cell Cord Blood Bank has released has proven to be viable upon thawing. Our perfect record allows us to offer the Cryo-Cell Cares $50,000 Payment Guarantee™. What's more, Cryo-Cell Cord Blood Bank processed and banked samples have been successfully used in a number of life-saving stem cell transplants. View transplant summary.
In addition to Cryo-Cell's high levels of accredited quality, we provide great value to our clients. Our prices are all-inclusive and remain several hundred dollars less than the industry's higher priced competitors.
Cryo-Cell Cord Blood Bank has a history of industry firsts. In addition to being a pioneer in cord blood banking, we, through our Saneron affiliate, are also on the forefront of cord blood research and development.
Your choice of a cord blood bank isn't something to experiment with-often there is safety in numbers. Cryo-Cell is one of the largest and most established cord blood banks. Don't trust your stem cells to a firm without a substantial track record.
Cryo-Cell International, Inc. has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Investor Relations: http://www.cryo-cell.com/investor_relations/
Investor Information: To request Cryo-Cell's Investor's Information Kit, or to receive Cryo-Cell's press releases via email, please fill out this form: http://www.cryo-cell.com/investor_relations/investor_info.asp
Section 16 Filings: All Insiders Annual Reports Quarterly & Other Reports Stock Quote Fundamentals News Chart Real-Time Filings
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York 10004
Investor Relations - Julia Avery
See SEC filing link for latest share structure info.
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp